THINQ PHARMA-CRO LTD

THINQ PHARMA-CRO LTD (India) holds 7 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 7 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “THINQ PHARMA-CRO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/thinq-pharma-cro-ltd

Overview

THINQ PHARMA-CRO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CETIRIZINE HYDROCHLORIDE USP; CIPROFLOXACIN HYDROCHLORIDE USP; FEXOFENADINE HYDROCHLORIDE USP; MECLIZINE HYDROCHLORIDE USP; OXYBUTYNIN CHLORIDE USP; POTASSIUM CHLORIDE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which THINQ PHARMA-CRO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

THINQ PHARMA-CRO LTD holds 7 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • SUCRALFATE USPActive2024-07-04
  • POTASSIUM CHLORIDE USPActive2023-09-29
  • FEXOFENADINE HYDROCHLORIDE USPActive2021-09-04
  • OXYBUTYNIN CHLORIDE USPActive2020-06-26
  • CIPROFLOXACIN HYDROCHLORIDE USPActive2016-06-27
  • MECLIZINE HYDROCHLORIDE USPActive2015-03-31
  • CETIRIZINE HYDROCHLORIDE USPActive2015-01-14

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to THINQ PHARMA-CRO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to THINQ PHARMA-CRO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this THINQ PHARMA-CRO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.